Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.
Manfredi RizzoAli A RizviAngelo Maria PattiDragana NikolicRosaria Vincenza GiglioGiuseppa CastellinoGiovanni Li VoltiMassimiliano CaprioGiuseppe MontaltoVincenzo ProvenzanoStefano GenoveseAntonio CerielloPublished in: Cardiovascular diabetology (2016)
Liraglutide improves cardio-metabolic risk factors in subjects with the MetS in a real-world study. Trial Registration ClinicalTrials.gov: NCT01715428.